CH640735A5 - Verfahren zum herstellen von virusantikoerpern. - Google Patents

Verfahren zum herstellen von virusantikoerpern. Download PDF

Info

Publication number
CH640735A5
CH640735A5 CH649278A CH649278A CH640735A5 CH 640735 A5 CH640735 A5 CH 640735A5 CH 649278 A CH649278 A CH 649278A CH 649278 A CH649278 A CH 649278A CH 640735 A5 CH640735 A5 CH 640735A5
Authority
CH
Switzerland
Prior art keywords
virus
antibodies
producing
hybrid
cell
Prior art date
Application number
CH649278A
Other languages
German (de)
English (en)
Inventor
Hilary Koprowski
Walter U Gerhard
Carlo M Croce
Original Assignee
Wistar Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wistar Inst filed Critical Wistar Inst
Publication of CH640735A5 publication Critical patent/CH640735A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CH649278A 1977-06-15 1978-06-14 Verfahren zum herstellen von virusantikoerpern. CH640735A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80685777A 1977-06-15 1977-06-15

Publications (1)

Publication Number Publication Date
CH640735A5 true CH640735A5 (de) 1984-01-31

Family

ID=25194989

Family Applications (1)

Application Number Title Priority Date Filing Date
CH649278A CH640735A5 (de) 1977-06-15 1978-06-14 Verfahren zum herstellen von virusantikoerpern.

Country Status (19)

Country Link
JP (2) JPS592276B2 (enrdf_load_stackoverflow)
AU (1) AU525724B2 (enrdf_load_stackoverflow)
BE (1) BE868099A (enrdf_load_stackoverflow)
CA (1) CA1103157A (enrdf_load_stackoverflow)
CH (1) CH640735A5 (enrdf_load_stackoverflow)
DE (1) DE2826075A1 (enrdf_load_stackoverflow)
DK (1) DK267378A (enrdf_load_stackoverflow)
ES (1) ES470729A1 (enrdf_load_stackoverflow)
FI (1) FI64952C (enrdf_load_stackoverflow)
FR (1) FR2394607A1 (enrdf_load_stackoverflow)
GB (1) GB2000186A (enrdf_load_stackoverflow)
IL (1) IL54908A (enrdf_load_stackoverflow)
IT (1) IT1096742B (enrdf_load_stackoverflow)
LU (1) LU79812A1 (enrdf_load_stackoverflow)
NL (1) NL7806471A (enrdf_load_stackoverflow)
NO (1) NO782081L (enrdf_load_stackoverflow)
PL (1) PL207652A1 (enrdf_load_stackoverflow)
SE (1) SE7806729L (enrdf_load_stackoverflow)
ZA (1) ZA783261B (enrdf_load_stackoverflow)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008092B1 (de) 1978-08-10 1982-07-28 Schering Aktiengesellschaft Verfahren zur Gewinnung von Immunglobulin-E-Antikörpern der Maus, die hierfür verwendbaren Hybridzellinien und deren Herstellung; Verwendung der so erhaltenen Immunglobulin-E-Antikörper
CA1142466A (en) * 1979-01-09 1983-03-08 Cesar Milstein Cell lines
US4271145A (en) * 1979-10-22 1981-06-02 The Massachusetts General Hospital Process for producing antibodies to hepatitis virus and cell lines therefor
EP0232921B1 (en) * 1980-04-09 1992-10-07 Btg International Limited Monoclonal antibodies against hepatitis b virus
US5204095A (en) * 1980-04-09 1993-04-20 National Research Development Corporation Monoclonal antibodies against hepatitis B virus
NL185309C (nl) * 1980-07-28 1990-03-01 Akzo Nv Methode voor het bepalen van antigenen met behulp van twee of meer monoklonale antilichamen alsmede immuunreagens.
JPS5825439B2 (ja) * 1980-12-30 1983-05-27 株式会社林原生物化学研究所 ヒト副甲状腺ホルモンの製造方法
US4608337A (en) * 1980-11-07 1986-08-26 The Wistar Institute Human hybridomas and the production of human monoclonal antibodies by human hybridomas
JPS609795B2 (ja) * 1980-12-11 1985-03-13 株式会社林原生物化学研究所 ヒト上皮細胞成長因子の製造方法
WO1982003089A1 (en) * 1981-03-06 1982-09-16 Lennox Edwin Samuel Monoclonal antibody
CA1262238A (en) * 1982-09-30 1989-10-10 Richard Insel Human monoclonal antibodies against bacterial toxins
JPH03271235A (ja) * 1983-04-08 1991-12-03 Kureha Chem Ind Co Ltd 抗カンジダ菌抗体分泌ハイブリドーマ
JPS60104020A (ja) * 1983-10-14 1985-06-08 メルク エンド カムパニー インコーポレーテツド A型肝炎‐タンパク質サブユニツト抗原
US4707442A (en) * 1983-10-24 1987-11-17 Board Of Regents, The University Of Texas System Hybrid cell line producing monoclonal antibody cytolytic to Trichomonas vaginalis
US4731237A (en) * 1983-11-07 1988-03-15 The Wistar Institute Immune response to virus induced by anti-idiotype antibodies
US5053224A (en) * 1983-11-07 1991-10-01 Hilary Koprowski Induction of antibody response to solid tumors with anti-idiotype antibodies
NL8401221A (nl) * 1984-04-16 1985-11-18 Innovi Nv Analytische toepassing van fagocyt-cellijnen.
JPS6140800A (ja) * 1984-07-27 1986-02-27 バイオテクノロジー アンド エクスペリメンタル リサーチ インコーポレーテツド 電気細胞融合法を用いたモノクローナル抗体の製造方法
EP0198086B1 (en) * 1984-09-28 1991-01-16 Teijin Limited Mouse human hybridoma producing antivirus human antibody, process for its preparation, and antivirus human monoclonal antibody
JPS6181782A (ja) * 1984-09-28 1986-04-25 Teijin Ltd 抗ウイルス・ヒト抗体を産生するマウス−ヒトハイブリド−マ及びその製造法並びにその使用方法
JPS6226300A (ja) * 1984-10-10 1987-02-04 セントコ−・インコ−ポレ−テツド Htlv−3dnaのクロ−ニングおよび発現
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
JPS61104796A (ja) * 1984-10-26 1986-05-23 Chemo Sero Therapeut Res Inst モノクロ−ナル抗体の製造方法
JP2518607B2 (ja) * 1985-08-29 1996-07-24 雪印乳業株式会社 インフルエンザa型ウイルスha抗原に対するモノクロ―ナル抗体およびその作成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3423505A (en) * 1964-10-31 1969-01-21 Univ Toronto Rabies vaccine and process for preparation thereof
US3585266A (en) * 1969-02-24 1971-06-15 Dow Chemical Co Live rabies virus vaccine and method for the production thereof

Also Published As

Publication number Publication date
IT7824577A0 (it) 1978-06-14
IL54908A (en) 1982-01-31
IT1096742B (it) 1985-08-26
JPS58101688A (ja) 1983-06-16
FI64952B (fi) 1983-10-31
AU3708878A (en) 1979-12-20
FR2394607B1 (enrdf_load_stackoverflow) 1983-12-30
BE868099A (fr) 1978-10-02
CA1103157A (en) 1981-06-16
DE2826075A1 (de) 1979-02-15
FI64952C (fi) 1984-02-10
FI781818A7 (fi) 1978-12-16
PL207652A1 (pl) 1979-06-04
DK267378A (da) 1978-12-16
DE2826075C2 (enrdf_load_stackoverflow) 1987-08-06
SE7806729L (sv) 1978-12-16
NL7806471A (nl) 1978-12-19
JPS5417185A (en) 1979-02-08
GB2000186A (en) 1979-01-04
NO782081L (no) 1978-12-15
FR2394607A1 (fr) 1979-01-12
ES470729A1 (es) 1979-01-16
ZA783261B (en) 1979-06-27
LU79812A1 (de) 1978-12-07
AU525724B2 (en) 1982-11-25
JPS592276B2 (ja) 1984-01-18
IL54908A0 (en) 1978-08-31

Similar Documents

Publication Publication Date Title
DE2826075C2 (enrdf_load_stackoverflow)
US4196265A (en) Method of producing antibodies
DE69126526T2 (de) Verfahren zur zellwachstumshinderung und dazu nützliche verbindungen
DE2840039C3 (de) Verfahren zur Erzeugung von Tumor-Antikörpern
DE3853779T2 (de) Hiv-1 neutralisierende monoklonale antikörper.
DE3650032T2 (de) Anticytomegaloviraler menschlicher monoklonaler antikörper und dessen herstellung.
DE3144181A1 (de) "human-myelomazell-linie und verfahren zur herstellung einer hybridzell-linie"
EP3615073A1 (de) Biologische bindemoleküle
DE4006630A1 (de) Humane monoklonale antikoerper gegen tollwutviren, ihre herstellung und verwendung
DE69005908T2 (de) Monoklonale Antikörper zur Behandlung nach einem Kontakt mit Tollwutvirus.
DE3855442T2 (de) Verfahren zur Gewinnung von Schutzantigenen gegen Bordetella-Infektionen und toxische Prozesse
DE69323130T2 (de) Avirulenter Tollwut-Impfstoff
DE3306060A1 (de) Neue immunglobulin-produzierende hybridzellinien, deren verwendung und verfahren zu deren herstellung
DE3854267T2 (de) HIV-spezifische monoklonale Antikörper und Hybridome zu ihrer Herstellung.
DE2362067C2 (de) Temperaturempfindliche, nicht-pathogene, infektiöse Rinder-Rhinotracheitis-Virusstämme, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Lebendimpfstoffen
DE3539775C2 (de) Neues Lymphokin, gegen dieses Lymphokin spezifische Antikörper, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3787239T2 (de) Komplementabhängiger zytolytischer monoklonaler Antikörper gegen Trichomonas vaginalis und seine therapeutische und diagnostische Verwendung.
EP3873526B1 (en) Anti-rabies monoclonal antibodies and cocktail thereof
DE3490527T (de) Neue monoklonale Antikörper
DE69328799T2 (de) Anti-Felincalicivirus rekombinanter Antikörper und dafür kodierendes Gen
EP0210552B1 (de) Tollwut-Lebendimpfstoff
DE69012034T2 (de) Monoklonaler Antikörper gegen Exotoxin A von Pseudomonas aeruginosa.
EP0157271B1 (de) Hybridzell-Linie, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3485994T2 (de) Herstellung und kennzeichnen von hybridoma antikoerpern spezifisch gerichtet gegen gemeinsame determinanten zwischen naheliegenden aber unterschiedlichen proteinen.
DE3587178T2 (de) Humaner monoklonaler antikoerper gegen pseudomonas aeruginosagegen pseudomonas aeruginosa produzierende hybridomen.

Legal Events

Date Code Title Description
PL Patent ceased